Nuzenio

Yahoo Finance Neurocrine

Yahoo Finance Neurocrine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 22:44:58 GMTNeurocrine Biosciences, Inc. (NB3.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Thu, 06 Aug 2026 01:53:30 GMTNeurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo Finance
Sat, 01 Aug 2026 07:00:00 GMTNeurocrine Biosciences (NBIX) Is Down 5.1% After Q2 Earnings Beat And Higher INGREZZA Guidance – What's Changed - Yahoo Finance
Sat, 01 Aug 2026 07:00:00 GMTNeurocrine Biosciences (NBIX) Appoints Four Senior Leaders As Pipeline And Portfolio Expand - Yahoo Finance
Fri, 31 Jul 2026 07:00:00 GMTRBC Lifts Price Target on Neurocrine Biosciences to $198 From $195, Keeps Outperform Rating - Yahoo Finance
Thu, 30 Jul 2026 07:00:00 GMTNeurocrine (NBIX) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yahoo Finance Neurocrine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.